Researchers have just revealed that a protein called MCL1, already known to help cancer cells avoid death, also orchestrates ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...

Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer development. These genetic alterations result in the creation of hybrid genes with ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...